AN1 28.6% 0.9¢ anagenics limited

Ann: AGM Presentation by CEO, page-15

  1. 63 Posts.
    Am very much a learner, so please feel free to confirm, deny or add to my findings.
    I don't hold yet but am looking to.
    At end of last quarter they only had $1.588m and needed $2.2m for expected current quarter outflow. So they cap raised $3m and currently have $4.588m.
    So they are covered for this quarter with $2.38m to spare - enough for the quarter after not including any revenues.
    If they lose the legal proceedings with Ikon and end up having to pay the $939k, then they are left with $1.44m - not enough for the next quarter, still not including any revenue. So revenue needs to be above $759k this quarter or there may be another CR.
    Sales were down 14% to $882k last quarter. An unlikely repeat of this drop would still bring in revenues of $758k - a smidgen under but possibly just enough to stay over the line.
    So from what I can gather, it really all hangs now in wether sales go up or down from the amount that is needed, and it's all a bit in limbo until something is released regarding the US launch and pre-sales starting from Nov 7, as this should be a pretty good indicator of future revenues.

    As I said, I'm a learner - so please feel free to tell me what I'm missing.
    Cheers.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.002(28.6%)
Mkt cap ! $4.152M
Open High Low Value Volume
1.6¢ 1.6¢ 0.9¢ $77.73K 5.481M

Buyers (Bids)

No. Vol. Price($)
3 3319000 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 227450 2
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
0.9¢
  Change
0.002 ( 43.8 %)
Open High Low Volume
1.4¢ 1.4¢ 0.9¢ 609000
Last updated 15.49pm 24/05/2024 ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.